Have a personal or library account? Click to login
Trends of Bloodstream Infections in a University Hospital During 12 Years Cover

Trends of Bloodstream Infections in a University Hospital During 12 Years

Open Access
|Sep 2022

Figures & Tables

Fig. 1

The most common microorganisms in all positive blood cultures over the 12 years.
The most common microorganisms in all positive blood cultures over the 12 years.

Fig. 2

Frequency of microorganisms within all positive blood cultures over the 12 years.
VRE – vancomycin-resistant enterococci, MRSA – methicillin-resistant S. aureus, ESBL – extended-spectrum β-lactamase
Frequency of microorganisms within all positive blood cultures over the 12 years. VRE – vancomycin-resistant enterococci, MRSA – methicillin-resistant S. aureus, ESBL – extended-spectrum β-lactamase

Distribution of microorganisms in bloodstream infections in the wards and intensive care units_

Bloodstream infection episodesWards n (%)Intensive care units n (%)Overall n (%)
MonomicrobialGram-negative3,065 (42.8%)710 (40.9%)3,775 (42.5%)
Escherichia coli971 (13.6%)57 (3.3%)1,028 (11.6%)
Klebsiella pneumoniae529 (7.4%)146 (8.4%)675 (7.6%)
Acinetobacter baumannii261 (3.6%)186 (10.7%)447 (5.0%)
Pseudomonas aeruginosa275 (3.8%)65 (3.7%)340 (3.8%)
Gram-positive2,289 (32.0%)441 (25.4%)2,730 (30.7%)
Coagulase-negative staphylococci(717 10%)(10.6184 %)(10.1901 %)
Staphylococcus aureus717 (10%)96 (5.5%)813 (9.1%)
Enterococcus faecalis188 (2.6%)57 (3.3%)245 (2.8%)
Enterococcus faecium191 (2.7%)38 (2.2%)229 (2.6%)
Fungi559 (7.8%)106 (6.1%)665 (7.5%)
Monomicrobial (Total)(5,913 82.7%)(1,257 72.3%)(7,170 80.6%)
Polymicrobial1,240 (17.3%)481 (27.7%)1,721 (19.4%)
Total7,153 (100%)1,738 (100%)8,891 (100%)

Antibiotic resistance rates of the most common Gram-negative bacteria in blood cultures_

Escherichia coli (%) (n= 1,360)PKlebsiella pneumoniae (%) (n= 1,031)PAcinetobacter baumannii (%) (n = 864)PPseudomonas aeruginosa (%) (n = 580)P
WardsICUOverallWardsICUOverallWardsICUOverallWardsICUOverall
Ceftriaxone25.723.825.60.6643850.441.1<0.00138.228.533.40.002----
Cefotaxime11.323.812.3<0.00110.720.213.1<0.00132.643.5380.001----
Cefepime36.949.537.90.01046.867.252<0.00147.762.555<0.00119.338.224.8<0.001
Imipenem1.411.30.58925.148.931.1<0.00174.988.781.7<0.00123.939.428.4<0.001
Meropenem0.910.90.62024.748.930.8<0.00174.790.782.6<0.00117.834.122.6<0.001
Ertapenem2.94.83.10.21925.646.630.9<0.0017674.375.20.55877.377.177.20.946
Piperacillm- Tazobactam23.825.7240.66350.572.556.1<0.0015066.758.2<0.00115.631.220.2<0.001
Amikacin1.41.91.40.4385.6219.5<0.00170.476.273.20.0535.48.26.20.265
Gentamicin26.136.226.80.02423.342.728.2<0.00162.275.268.6<0.00112.226.516.4<0.001
Colistin0.210.30.275614.18.1<0.0012.31.41.80.4770.71.20.90.633
Fosfomycin000-0.81.10.90.4111.60.91.30.570----
Ciprofloxacin44.644.844.60.97837.269.845.5<0.00181.296.888.9<0.00111.22013.80.008
ESBL36.643.837.10.08645.956.948.70.001--------
Carbapenem- resistant3.34.83.50.29429.858.437.1<0.00190.593.892.10.08083.488.284.80.162

Antibiotic resistance rates of the most common Gram-positive bacteria in blood cultures_

Staphylococcus aureus (%) (n = 996)pCoagulase-negative staphylococci (%) (n = 1,382)pEnterococcus faecalis/ Enterococcus faecium (%) (n = 1,036)p
WardsICUOverall WardsICUOverall WardsICUOverall
Daptomycin000000111
Oxacillin16.637.719.7< 0.00182.990.184.70.001111
Vancomycin00000010.98.110.10.185
Teicoplanin0.80.70.80.6686.597.10.15510.48.19.70.273
Linezolid0000.70.60.70.62411.11.10.587
Penicillin11111138.82635.4< 0.001
High-gentamicin level22222243.54844.70.202
DOI: https://doi.org/10.33073/pjm-2022-039 | Journal eISSN: 2544-4646 | Journal ISSN: 1733-1331
Language: English
Page range: 443 - 452
Submitted on: May 26, 2022
Accepted on: Jul 27, 2022
Published on: Sep 24, 2022
Published by: Polish Society of Microbiologists
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Nazmiye Ülkü Tüzemen, Melda Payaslioğlu, Cüneyt Özakin, Beyza Ener, Halis Akalin, published by Polish Society of Microbiologists
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.